Given that TGF-β is a key factor suppressing NK cell function (38), we hypothesize that RELT may also suppress NK cell activity in ccRCC by interacting synergistically with TGF-β within the inflammatory environment created by IL-6. Here, TGFB1 is linked to nonpapillary renal cell carcinoma.